Encompass (EHC) Narx-foyda multiplikatori

Encompass Health Corp - EHC emitenti grafik logotipi

Encompass Health davlat sug'urta dasturlari orqali qarib borayotgan aholidan barqaror ijara to'lovlarini oladi. Biznes savdo mojarolaridan himoyalangan, garchi dori-darmon xarajatlaridagi inflyatsiya marjalarni qisqartirayotgan bo'lsa-da. GURU.Markets platformasida kompaniyaning yillik P/E ko'rsatkichini ko'zdan kechirib, 22.00 qiymati joriy metrikani ifodalashini qayd etish mumkin. Shu bilan birga, tarmoq uskunalarni muntazam yangilab borish orqali karavotlarning yuqori bandlik darajasini saqlab qolmoqda.

EHC: Encompass Health Inc. P/E multiplikatori 04.07.2022 - 10.11.2026

Encompass Health Inc. (EHC) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor narxi va tahlilchilarning maqsadli narxlari:
Birja narxi encompasshealth.com|EHC - Maqsadli narxlar grafigi
- bozor kapitallashuvi tafsilotlari:
Bozor kapitallashuvi Encompass Health Corporation|EHC - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- emitentning balans qiymati statistikasi:
Aksiyaning balans narxi Encompass Health|EHC - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti encompasshealth.com|EHC - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Encompass Health|EHC - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Encompass|EHC - Kompaniya qarzlari|Balans qiymatiga qarzlar Encompass Health Corporation|EHC - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Encompass Health|Kritik likvidlik koeffitsiyenti encompasshealth.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
EHC - Sof foyda|Prognoz qilingan kelajakdagi foyda Encompass Health|EHC - Narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Encompass Health Corp|EHC - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Encompass Health Corporation|EHC - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Encompass Health|EHC - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi encompasshealth.com|EHC - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Encompass Health
Kompaniyaning har tomonlama tahlili:EHC (encompasshealth.com)
Encompass Health tovar namunasi

Reabilitatsiya sektoridagi yuqori litsenziyalash to'siqlari Encompass Health (EHC) biznesini barqaror qiladi, bu esa aktivning narx dinamikasida aks etgan. Ushbu ko'rsatkich bozor kapitalizatsiyasining sof foydaga nisbati sifatida hisoblanadi va investitsiyalarning qoplanish muddatini o'lchaydi. Kompaniyaning fundamental P/E ko'paytiruvchisini tahlil qilish joriy narx va biznesning ichki qiymati o'rtasidagi farqlarni aniqlash imkonini beradi. Bu investorlarga sanoatga yangi ishtirokchilar kirishining cheklanganligi uchun to'lanayotgan premium asosli yoki yo'qligini baholashga yordam beradi.

Raqobatdosh kompaniyalar tahlili

Kapitalizatsiyaning foydaga nisbati HCA Holdings HCA|Narxning foydaga nisbati Tenet Healthcare Corporation (THC)|Fresenius Medical Care AG - Narx-foyda multiplikatori|Solventum Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati UHS (Universal Health Services Inc)|DaVita Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati radnet.com|Option Care Health, Inc. (OPCH) - Narxning foydaga nisbati|Narx-foyda multiplikatori SGRY|PINC (Premier Corp) - P/E multiplikatori|Narx-foyda koeffitsiyenti America's Best Contacts & Eyeglasses (EYE)|Narxning foydaga nisbati Progyny, Inc. (PGNY)|ARDT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Select Medical Holdings SEM|ASTH - Narx-foyda koeffitsiyenti|MD - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati USPH|PNTG: P/E multiplikatori|organogenesis.com (ORGO) - P/E multiplikatori|Narxning foydaga nisbati Nutex Health|Auna S.A. (AUNA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati SBC Medical Corp (SBC)|Biznesning o‘zini qoplash muddati Evolus Corp|Community Health Systems - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati SKIN|MediWound, Ltd. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati BTMD (Biote)|JYNT: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati DocGo, Inc (DCGO)|PIII (P3 Health Partners, Inc.) - P/E multiplikatori|P/E multiplikatori gaintherapeutics.com|Narxning foydaga nisbati EUDA Health Holdings Limited (EUDA)|Narxning foydaga nisbati BMGL (baselmedical.com)|CollPlant Biotechnologies Ltd. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati CUPR (Cuprina Holdings Limited)|Concord Medical Services - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati AMS (ashs.com)|MRM: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Avalon GloboCare Corp. (ALBT)|DHAI (DIH Holding US Inc.) - P/E multiplikatori|XAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NIVF|Narx-foyda koeffitsiyenti atipt.com ATIP|CareMax - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati KDLY (Kindly MD Inc)|MODV - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati NVOS (Novo Integrated Sciences Corp)|SSY: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati imacholdings.comm (BACK)